SecBot SecBot
COURT-RULING ·Filed Jul 31, 2026

TEVA

TEVA PHARMACEUTICAL INDUSTRIES LTD
BULLISH
Impact 7/10
Horizonimmediate Processed3mo ago CourtCourt Ruling · govinfo.gov
Court ruling (district)
Actionable Insight ▲ Bullish

Teva has eliminated the core RICO exposure in this case, removing a significant litigation overhang. Monitor the separate order on state-law claims for any remaining financial exposure. The ruling reinforces Teva's legal position in similar co-pay charity cases and removes a key uncertainty for the stock.

DirectionBullish
Confidencehigh
Horizonimmediate

How the stock moved after the report

BULLISH VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$34.46
T+0 close · Aug 3, 2026 · via day close
Latest settled
+17.18%
T+60 · $40.38
Vs SPY
+15.40%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Aug 3 $34.46entry
  2. T+1 · 4mo ago −0.09%α −1.89% · $34.43
  3. T+5 · 3mo ago +4.88%α +2.85% · $36.14
  4. T+20 · 3mo ago +4.61%α +3.38% · $36.05
  5. T+60 · 21d ago +17.18%α +15.40% · $40.38
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Teva won summary judgment dismissing United Healthcare's RICO claims as time-barred. The court held that storm warnings, including a 2005 WSJ article quoting a Teva executive, extensive media coverage, and the 2017 IRS investigation into Teva's Copaxone co-pay charity donations, put United on inquiry notice by November 2018, four years before it sued. The ruling eliminates material RICO exposure for Teva, though state-law claims remain pending in a separate order.

Court Ruling Details

Ruling Date
Jul 31, 2026
Court
United States District Court for the District of New Jersey
Court Level
District
Judge
Michael E. Farbiarz
Case Type
other
Ruling Type
summary judgment
Outcome
WIN: ruling favors this company
Appeal Timeline
1-2 years for Third Circuit appeal
Precedent Risk
LOW

Key Facts

  • Teva's motion for summary judgment on statute-of-limitations grounds was GRANTED as to all federal RICO claims.
  • The court found storm warnings existed by November 2018, including a 2005 WSJ article quoting a Teva executive, 2013-2017 media coverage, and the 2017 IRS investigation into Teva's donations to the Chronic Disease Fund (CDF) for Copaxone co-pays.
  • The Teva-CDF donation agreement, publicly filed in 2017, explicitly stated CDF would use Teva donations to cover Copaxone co-pays and provide detailed weekly/monthly reports to Teva.
  • The court held that United Healthcare, as a sophisticated insurer, should have known of these warnings and that its RICO claims were filed too late.
  • State-law claims (fraudulent concealment, tortious interference, unjust enrichment, consumer protection) were addressed in a separate order and remain pending.
  • No damages were awarded; the ruling eliminates the RICO claims entirely.

Financial Impact

RICO claims dismissed, no damages awarded. The complaint sought unspecified millions in alleged overpayments for Copaxone. State-law claims remain pending.

legal_exposurelitigation_risk

Risk Factors

  • State-law claims remain pending and could still result in damages or settlement costs.
  • The ruling may be appealed by United Healthcare to the Third Circuit.
  • Other insurers may bring similar claims based on the same alleged conduct, though this ruling creates a strong statute-of-limitations defense.

Market Snapshot

Exchange
OTC
Sector
Pharmaceutical Preparations
Analyst Consensus
86% bullish (7 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 court opinion.

DocumentAccession Number
COURT-RULING Data (Synthetic)court-12221f377c-TEVA

Track record

61 reports on TEVA

Performance horizon

5 of 7 bullish or bearish reports moved the stock their way by T+60. Best: +33.06% at T+60 after the Jul 20, 2026 report. 14 of 16 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $43.16 Now $42.57 −1.37% settles Feb 12
  2. Nov 12, 20264d ago 3 Neutral 2/10 Entry $44.50 Now $42.57 −4.34% settles Feb 11
  3. Nov 12, 20264d ago 144 Neutral 2/10 Entry $44.50 Now $42.57 −4.34% settles Feb 11
  4. Nov 12, 20264d ago 144 Neutral 2/10 Entry $43.65 Now $42.57 −2.47% settles Feb 10
  5. Nov 10, 20266d ago 144 Neutral 3/10 Entry $43.24 Now $42.57 −1.55% settles Feb 9
  6. Nov 10, 20266d ago SC 13G/A Neutral 3/10 Entry $42.40 Now $42.57 +0.40% settles Feb 8
  7. Nov 9, 20267d ago 144 Neutral 2/10 Entry $42.40 Now $42.57 +0.40% settles Feb 8
  8. Nov 6, 202610d ago Insider Cluster Neutral 3/10 Entry $42.97 Now $42.57 −0.93% settles Feb 5
  9. Nov 6, 202610d ago Insider Cluster Neutral 2/10 Entry $42.97 Now $42.57 −0.93% settles Feb 5
  10. Nov 5, 202611d ago 144 Neutral 2/10 Entry $42.61 Now $42.57 −0.09% settles Feb 4
Showing 10 of 61

US Market Status

Market Closed · Opens in 8h 45m

Subscribe to SecBot

Get Real-Time Court Ruling Intelligence

Market-moving court rulings analyzed within minutes. Patent verdicts, antitrust decisions, class certifications, and more, parsed and scored by AI.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
⚖ Court Ruling · govinfo.gov Report published Aug 1, 2026